April 18th 2024
Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Read More
Dysmenorrhea management via telemedicine vs. in-person visits only
March 12th 2024Investigating dysmenorrhea outcomes with low-dose pill prescriptions reveals no significant difference between combination telemedicine and in-person consultations vs in-person only, prompting further exploration into telemedicine's role in gynecological care.
Read More
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Read More
Study: Antibiotic therapy reduces intraamniotic inflammation in second trimester idiopathic bleeding
March 1st 2024A recent study revealed the efficacy of antibiotic therapy in reducing intraamniotic inflammation among patients experiencing idiopathic bleeding in the second trimester of pregnancy, shedding light on potential management strategies for this condition.
Read More
FDA approves enmetazobactam for treatment of cUTIs
February 23rd 2024Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.
Read More
Open vs minimally invasive hysterectomy outcomes with enhanced recovery after surgery
February 21st 2024Discover how immediate postoperative symptom burden varies between open and minimally invasive hysterectomies under enhanced recovery after surgery protocols, shedding light on recovery disparities in gynecologic surgery.
Read More
Study finds relugolix-CT Improves HMB in Black women
February 19th 2024Recent research highlights the efficacy and safety of relugolix combination therapy in managing uterine fibroid-associated heavy menstrual bleeding specifically among Black women, demonstrating outcomes comparable to the broader population.
Read More
Study on PCOS and suicide risk reveals correlation
February 9th 2024A recent study revealed an 8.47-fold increased risk of suicide attempts among individuals with polycystic ovary syndrome, prompting the need for proactive mental health management in patients and improved tools for assessing health-related quality-of-life.
Read More
Urodynamics and the role of lidocaine
February 5th 2024Explore the potential benefits and considerations of utilizing intraurethral lidocaine jelly during urodynamic studies for bladder testing, as we delve into research findings on patient discomfort, voiding metrics, and diagnostic precision.
Read More
The impact of physician awareness on decision-making preferences in urogynecology
January 16th 2024A recent study revealed that physician awareness of patients' desired level of decision-making significantly enhances satisfaction, highlighting the importance of tailored approaches for women with pelvic floor disorders seeking patient-centered care.
Read More
Elevated bilateral salpingo-oophorectomy rates in women with disabilities
December 14th 2023A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.
Read More
FDA grants IND clearance to DARE-VVA1 for dyspareunia
December 7th 2023Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Read More